Omada grows revenue, membership in public earnings debut
Drivers of revenue growth included more customers using multiple chronic condition programs as well as strong adoption of GLP-1 offerings....
.
Drivers of revenue growth included more customers using multiple chronic condition programs as well as strong adoption of GLP-1 offerings....
The nonprofit highlighted non-hormonal contraception and preeclampsia treatment as areas of “breakthrough potential.” Article By: Delilah Alvarado Blog Source From :...
The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data...
The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs...
Medtronic and Recor Medical stand to benefit from national Medicare coverage for their new device-based treatments for patients with uncontrolled...
A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for generic drugs....
A large portion of the 1.22 million jobs that could be lost nationwide in 2029 would come from the healthcare...
Providers will need to make difficult decisions amid growing headwinds, according to a new report from S&P Global Ratings. Choices...
The health system is currently testing the agentic tool at two subsidiaries, with plans to roll out the technology at...
The guidance should help health systems safely manage and monitor AI tools in a financially sustainable manner, which can be...